Diving into drug-screening: zebrafish embryos as an <i>in vivo</i> platform for antimicrobial drug discovery and assessmentEva Habjan, Wilbert Bitter, Gina K. Schouten et al.|FEMS Microbiology Reviews|2024Cited by 33
An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitorEva Habjan, Alexander Speer, Vien Q. T. Ho et al.|Disease Models & Mechanisms|2021Cited by 29
Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazolesVien Q. T. Ho, Alexander Speer, Mark K. Rong et al.|Biomolecules|2023Cited by 11
Heterologous Expression of <i>ethA</i> and <i>katG</i> in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosisVien Q. T. Ho, Alexander Speer, Wilbert Bitter et al.|Antimicrobial Agents and Chemotherapy|2021Cited by 11
Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazolesEva Habjan, Alexander Speer, Alexander Lepioshkin et al.|Life Science Alliance|2024Cited by 4